✦ LIBER ✦

Safety of bevacizumab in patients with malignant gliomas: a systematic review

✍ Scribed by Simonetti, G.; Trevisan, E.; Silvani, A.; Gaviani, P.; Botturi, A.; Lamperti, E.; Beecher, D.; Bertero, L.; Bosa, C.; Salmaggi, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Efficacy of Stereotactic Radi

✍ Kyle C. Cuneo; James J. Vredenburgh; John H. Sampson; David A. Reardon; Annick D 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Effects of bevacizumab plus irinotecan o

✍ Tao Xu; Juxiang Chen; Yicheng Lu; Johannes EA Wolff 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 795 KB

Safety of bevacizumab with or without an

✍ Simonetti, G.; Trevisan, E.; Gaviani, P.; Lamperti, E.; Salmaggi, A.; Silvani, A 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Safety of concurrent bevacizumab therapy

✍ Andrew D. Norden; Julia Bartolomeo; Shota Tanaka; Jan Drappatz; Abigail S. Ciamp 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 257 KB

Radiotherapy for newly diagnosed maligna

✍ Normand Laperriere; Lisa Zuraw; Gregory Cairncross 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Bevacizumab in Patients Treated with Ste

✍ K.C. Cuneo; J.J. Vredenburgh; J.H. Sampson; D.A. Reardon; A. Desjardins; C.G. Wi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB